TrialBritish journal of haematology2018

A phase II study of vascular endothelial growth factor trap (Aflibercept, NSC 724770) in patients with myelodysplastic syndrome: a California Cancer Consortium Study.

Mark H Kirschbaum et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.